[ESBL and carbapenemases in Enterobacteriaceae]

A Cherkaoui; S Emonet; G Renzi; A Riat; G Greub; J Schrenzel

[ESBL and carbapenemases in Enterobacteriaceae]

Rev Med Suisse. 2014 Nov 12;10(450):2142-8.

[Article in French]

Authors

A Cherkaoui¹, S Emonet, G Renzi, A Riat, G Greub, J Schrenzel

Affiliation

¹ Laboratoire de bactériologie, HUG, Genève. abdessalam.cherkaoui@hcuge.ch

PMID: 25549375

Abstract

Carbapenemase-producing enterobacteria (CPE) spread all over the world during the last years, causing serious infections with increasing frequency. Very few new drugs active against CPE are expected to be clinically available. Studies summarized in this review show that there is yet room to improve our therapeutic approaches, in the treatment of infections due to CPE.

Publication types

English Abstract
Review

MeSH terms

Anti-Bacterial Agents / pharmacology
Bacterial Proteins / metabolism*
Drug Design
Enterobacteriaceae / enzymology*
Enterobacteriaceae Infections / drug therapy*
Enterobacteriaceae Infections / microbiology
Humans
Microbial Sensitivity Tests
beta-Lactamases / metabolism*

Substances

Anti-Bacterial Agents
Bacterial Proteins
beta-Lactamases
carbapenemase